Arrowhead Pharmaceuticals, INC. (ARWR) SEC Filings — 2024
18 SEC filings for Arrowhead Pharmaceuticals, INC. (ARWR) in 2024.
Filings
- Arrowhead Pharmaceuticals Appoints New Director — 8-K · Dec 18, 2024
- Arrowhead Pharmaceuticals, INC. 10-K Filing — 10-K · Nov 26, 2024
- Arrowhead Pharmaceuticals, INC. SC 13G Filing — SC 13G · Nov 14, 2024
- Arrowhead Pharmaceuticals, INC. SC 13G/A Filing — SC 13G/A · Oct 16, 2024
- Arrowhead Pharmaceuticals Files Q3 2024 10-Q — 10-Q · Aug 8, 2024
- Arrowhead Pharma Files Q2 2024 10-Q — 10-Q · May 9, 2024
- Arrowhead Pharmaceuticals, INC. SC 13G/A Filing — SC 13G/A · Apr 10, 2024
- Arrowhead Pharmaceuticals Files 8-K — 8-K · Mar 19, 2024
- Arrowhead Pharma Files 8-K/A Amendment — 8-K/A · Mar 18, 2024
- Arrowhead Pharma Files Definitive Additional Proxy Materials — DEFA14A · Feb 27, 2024
- Arrowhead Pharma Files 8-K on Officer Compensatory Arrangements — 8-K · Feb 22, 2024
- Vanguard Group Updates 9.4% Stake in Arrowhead Pharma — SC 13G/A · Feb 13, 2024
- Arrowhead Pharmaceuticals, Inc. Files 10-Q for Period Ending December 31, 2023 — 10-Q · Feb 6, 2024
- Arrowhead Pharmaceuticals, Inc. Files Definitive Proxy Statement — DEF 14A · Jan 26, 2024
- State Street Corp Amends Passive Stake in Arrowhead Pharma — SC 13G/A · Jan 24, 2024
- BlackRock Trims Arrowhead Pharma Stake to 6.6% — SC 13G/A · Jan 23, 2024
- Arrowhead Pharma Reports Executive Compensation Changes — 8-K · Jan 22, 2024
- Arrowhead Pharma Enters Material Definitive Agreement — 8-K · Jan 4, 2024